08/13/2024
ACCP seeks qualified applicants for the position of Editor-in-Chief of the Clinical Pharmacology in Drug Development (CPDD).
To view the job description and request for applications please visit
https://bit.ly/4bMi2h8
The due date for applications is September 20, 2024.
The CPDD is one of the two official publications of the ACCP and is an international, peer-reviewed journal focused on publishing high-quality clinical pharmacology studies in drug development which are primarily (but not exclusively) performed in healthy subjects during the early phases of drug development, or after marketing approval. Acceptance of a manuscript in CPDD is determined by scientific rigor and technical soundness rather than perceived importance of the presented results. In addition to publication of original research articles, CPDD encourages submission (with or without invitation) of Editorials, Commentaries and Reviews.
Since its introduction in 2012, CPDD has included an international Editorial Board consisting of basic and clinical scientists who are well-established in the field of clinical pharmacology and represent academic, regulatory and industry sectors. The Editorial Board works closely with the Editor-in-Chief to provide strategic oversight and guidance, as well as to assist with operational requirements.
The CPDD is published by Wiley Periodicals Inc, a subsidiary of John Wiley & Sons Inc (Publisher).
We encourage you to share this with qualified colleagues who may wish to apply.